海外の治験の状況「脳卒中」での検索結果
122件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Authorised
- Inflammation inhibitors to reduce brain injury after a hemorrhagic stroke.
- Aneurysmal subarachnoid hemorrhage MedDRA version: 20.1 Level: LLT Classification code 10042320 Term: Subarachnoid hemorrhage System Organ Class: 100000004863 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Netherlands
- 2018-01-10
Authorised
- An open safety study with the monoaminergic stabilizer (-)-OSU6162 in patients with mental fatigue and related vitality and wakefulness disturbances associated with neurologiacal disorders, e g Parkinson’s disease, Huntington’s disease, brain trauma, stroke, myalgic encephalomyelitis and narcolepsy.
- Parkinsons disease Huntingtons disease Multiple scleros Brain trauma Stroke Myalgic encephalomyelitis Narcolepsy;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Sweden
- 2013-11-11
Authorised
- Estudio doble ciego, aleatorizado, controlado con placebo de dosis escaladas de deferoxamina intravenosa en pacientes con ictus isquémico agudo tratado con activador tisular del plasminógeno. Double-blind, randomized, placebo controlled, dose-finding phase II clinical trial of intravenous deferoxamine in patients with acute ischemic stroke treated with tissue plasminogen activator. - tandem-1
- La deferoxamina es un neuroprotector en modelos animales de isquemia/reperfusión cerebral. Si la deferoxamina es segura y bien tolerada en pacientes con ictus agudo puede significar una nueva estrategia terapéutica en la isquemia/reperfusión cerebral. Deferoxamine is neuroprotective in ischemia/reperfusion animal models. If deferoxamine demonstrate to be secure and well tolerated in acute stroke patients, it may be a new therapy after ischemia and reperfusion. MedDRA version: 9.1 Level: LLT Classification code 10027580 Term: Middle cerebral artery stroke
- Spain
- 2008-01-28
Authorised
- Effect of Aggrenox® / Asasantin® Retard compared with Clopidogrel on Endothelial function as measured by Microalbuminuria, Inflammatory markers CRP, MCP-1, and MMP-9 in Patients with Type 2 Diabetes Mellitus and a history of TIA or stroke. - Aggrenox in Diabetic patients study
- Patients with Type 2 Diabetes Mellitus and a history of TIA or stroke. br>MedDRA version: 9.1 Level: LLT Classification code 10012613 Term: Diabetes mellitus non-insulin-dependent MedDRA version: 9.1 Level: LLT Classification code 10023027 Term: Ischaemic stroke NOS br>MedDRA version: 9.1 Level: LLT Classification code 10044391 Term: Transient ischemic attacks
- Norway
- 2008-11-26
Authorised
- SO03-01 - EVALUATION OF THE EFFECT OF N-3 SUPPLEMENTATION ON FUNCTIONAL IMPROVEMENT IN POSTSTROKE PATIENTS - SO3-01
- Post ischemic stroke
- Italy
- 2009-09-10
Authorised
- Tratamiento de la Afasia Post-ictus con Donepezilo y Rehabilitación Grupal Intensiva de la Afasia: Análisis de la Reorganización Funcional de la Redes del Lenguaje con Neuroimagen Estructural y Funcional. Treatment of post-stroke aphasia with donepezil and constraint-induced aphasia therapy: Analysis of functional reorganization of language networks with structural and functional neuroimaging
- Tratamiento de la Afasia crónica con Donepezilo Treatment of chronic aphasia with Donepecil MedDRA version: 9 Level: PT Classification code 10002948 Term: Aphasia
- Spain
- 2010-02-19
Authorised
- Potentiation of procedural motor learning by pharmacological neuromodulation and brain stimulation - Potentiation of procedural motor learning
- Healthy volunteers Patients in the chronic stage (> 1 year) after stroke
- Germany
- 2005-08-08
Authorised
- Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT)
- Patients with a history of acute stroke due to Intracranial Haemorrhage with mild to moderately high blood pressure. MedDRA version: 20.1 Level: PT Classification code 10019016 Term: Haemorrhagic stroke System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Australia, Brazil, Canada, China, India, Japan, Korea, Republic of, Malaysia, Netherlands, New Zealand, Pakistan, Philippines, Sri Lanka, Taiwan, United Kingdom, Vietnam
- 2018-05-15
Authorised
- Single Center Pilot Clinical Trial on cell therapy in acute ictus
- acute ischemic stroke br>MedDRA version: 14.1 Level: PT Classification code 10061256 Term: Ischaemic stroke System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Spain
- 2011-12-07
Authorised
- Efficacy and safety trial with S 44819 after recent ischemic cerebral event
- Post stroke recovery br>MedDRA version: 19.0 Level: PT Classification code 10061256 Term: Ischaemic stroke System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Belgium, Brazil, Canada, Czech Republic, France, Germany, Hungary, Italy, Netherlands, Poland, Spain, Sweden, United Kingdom
- 2016-06-21
